$PDLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PDL BIOPHARMA, INC.. Get notifications about new insider transactions in PDL BIOPHARMA, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 11 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 9.50 | 500 | 4,750 | 10,000 | 9.5 K to 10 K (+5.26 %) |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | EVP & CSO | Option Exercise | M | 7.85 | 20,000 | 157,000 | 10,625 | |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | EVP & CSO | Buy | M | 7.85 | 20,000 | 157,000 | 73,125 | 53.1 K to 73.1 K (+37.65 %) |
| May 06 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 9.60 | 500 | 4,800 | 9,500 | 9 K to 9.5 K (+5.56 %) |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Chairperson of the ... | Option Exercise | M | 13.55 | 250 | 3,388 | 0 | |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Chairperson of the ... | Buy | M | 13.55 | 250 | 3,388 | 2,250 | 2 K to 2.3 K (+12.50 %) |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP, Mktg & Bus. Af ... | Option Exercise | M | 7.83 | 313 | 2,451 | 0 | |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP, Mktg & Bus. Af ... | Option Exercise | M | 9.00 | 469 | 4,221 | 0 | |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP, Mktg & Bus. Af ... | Option Exercise | M | 8.55 | 469 | 4,010 | 0 | |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP, Mktg & Bus. Af ... | Buy | M | 7.83 | 313 | 2,451 | 16,125 | 15.8 K to 16.1 K (+1.98 %) |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP, Mktg & Bus. Af ... | Buy | M | 9.00 | 469 | 4,221 | 15,812 | 15.3 K to 15.8 K (+3.06 %) |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP, Mktg & Bus. Af ... | Buy | M | 8.55 | 469 | 4,010 | 15,343 | 14.9 K to 15.3 K (+3.15 %) |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Interim CEO | Option Exercise | M | 7.01 | 12,000 | 84,120 | 0 | |
| Apr 30 2008 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Interim CEO | Buy | M | 7.01 | 12,000 | 84,120 | 19,555 | 7.6 K to 19.6 K (+158.84 %) |
| Apr 21 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 13.88 | 200 | 2,776 | 9,000 | 8.8 K to 9 K (+2.27 %) |
| Apr 21 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 13.87 | 300 | 4,161 | 8,800 | 8.5 K to 8.8 K (+3.53 %) |
| Apr 07 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 11.38 | 300 | 3,414 | 8,500 | 8.2 K to 8.5 K (+3.66 %) |
| Apr 07 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 11.38 | 200 | 2,276 | 8,200 | 8 K to 8.2 K (+2.50 %) |
| Apr 10 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 4.25 | 120,000 | 510,000 | 0 | |
| Apr 10 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 4.25 | 120,000 | 510,000 | 421,680 | 301.7 K to 421.7 K (+39.78 %) |
| Apr 01 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 9.66 | 93,200 | 899,958 | 0 | |
| Apr 01 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 9.66 | 93,200 | 899,958 | 301,680 | 208.5 K to 301.7 K (+44.70 %) |
| Mar 20 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 9.52 | 500 | 4,760 | 8,000 | 7.5 K to 8 K (+6.67 %) |
| Mar 10 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 10.60 | 500 | 5,300 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| Mar 10 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 9.66 | 20,600 | 198,918 | 93,200 | |
| Mar 10 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 9.66 | 20,600 | 198,918 | 208,480 | 187.9 K to 208.5 K (+10.96 %) |
| Mar 05 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 9.66 | 35,360 | 341,443 | 113,800 | |
| Mar 05 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 9.66 | 35,360 | 341,443 | 187,880 | 152.5 K to 187.9 K (+23.18 %) |
| Feb 28 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 9.66 | 10,840 | 104,673 | 149,160 | |
| Feb 28 2008 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 9.66 | 10,840 | 104,673 | 152,520 | 141.7 K to 152.5 K (+7.65 %) |
| Feb 21 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 15.65 | 100 | 1,565 | 7,000 | 6.9 K to 7 K (+1.45 %) |
| Feb 21 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 15.65 | 400 | 6,260 | 6,900 | 6.5 K to 6.9 K (+6.15 %) |
| Feb 06 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 14.20 | 500 | 7,100 | 6,500 | 6 K to 6.5 K (+8.33 %) |
| Feb 01 2008 | PDLI | PDL BIOPHARMA, INC ... | Sarena Francis Willard | Exec Dir/Chief Lega ... | Grant | A | 0.00 | 2,000 | 0 | 6,292 | 4.3 K to 6.3 K (+46.60 %) |
| Jan 23 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 15.01 | 100 | 1,501 | 6,000 | 5.9 K to 6 K (+1.69 %) |
| Jan 23 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 15.03 | 300 | 4,509 | 5,900 | 5.6 K to 5.9 K (+5.36 %) |
| Jan 23 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 15.04 | 100 | 1,504 | 5,600 | 5.5 K to 5.6 K (+1.82 %) |
| Jan 09 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 16.27 | 100 | 1,627 | 5,500 | 5.4 K to 5.5 K (+1.85 %) |
| Jan 09 2008 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 16.27 | 400 | 6,508 | 5,400 | 5 K to 5.4 K (+8.00 %) |
| Jan 03 2008 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 17.26 | 60 | 1,036 | 0 | 60 to 0 (-100.00 %) |
| Jan 03 2008 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 17.19 | 95 | 1,633 | 60 | 155 to 60 (-61.29 %) |
| Jan 03 2008 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 17.14 | 20 | 343 | 155 | 175 to 155 (-11.43 %) |
| Jan 03 2008 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 17.12 | 27 | 462 | 185 | 212 to 185 (-12.74 %) |
| Jan 03 2008 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 17.06 | 85 | 1,450 | 212 | 297 to 212 (-28.62 %) |
| Jan 03 2008 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 17.41 | 50 | 871 | 297 | 347 to 297 (-14.41 %) |
| Dec 20 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 17.00 | 300 | 5,100 | 5,000 | 4.7 K to 5 K (+6.38 %) |
| Dec 20 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 16.99 | 200 | 3,398 | 4,700 | 4.5 K to 4.7 K (+4.44 %) |
| Dec 20 2007 | PDLI | PDL BIOPHARMA, INC ... | CROSS HERB | Corp Controller/Pri ... | Grant | A | 0.00 | 1,000 | 0 | 5,122 | 4.1 K to 5.1 K (+24.26 %) |
| Dec 06 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 17.15 | 500 | 8,575 | 4,500 | 4 K to 4.5 K (+12.50 %) |
| Nov 20 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 17.86 | 500 | 8,930 | 4,000 | 3.5 K to 4 K (+14.29 %) |
| Nov 19 2007 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Interim CEO | Option Exercise | A | 18.03 | 100,000 | 1,803,000 | 100,000 | |
| Nov 06 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 20.72 | 500 | 10,360 | 3,500 | 3 K to 3.5 K (+16.67 %) |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 37,197 | |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.24 | 250 | 5,310 | 0 | 250 to 0 (-100.00 %) |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.00 | 250 | 5,250 | 250 | 500 to 250 (-50.00 %) |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.99 | 437 | 9,173 | 500 | 937 to 500 (-46.64 %) |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.98 | 400 | 8,392 | 937 | 1.3 K to 937 (-29.92 %) |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.96 | 250 | 5,240 | 1,337 | 1.6 K to 1.3 K (-15.75 %) |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.95 | 600 | 12,570 | 1,587 | 2.2 K to 1.6 K (-27.43 %) |
| Oct 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
| Oct 22 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 20.10 | 500 | 10,050 | 3,000 | 2.5 K to 3 K (+20.00 %) |
| Oct 09 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 23.43 | 100 | 2,343 | 2,500 | 2.4 K to 2.5 K (+4.17 %) |
| Oct 09 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 23.42 | 400 | 9,368 | 2,400 | 2 K to 2.4 K (+20.00 %) |
| Oct 03 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 21,970 | |
| Oct 03 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.58 | 645 | 14,564 | 0 | 645 to 0 (-100.00 %) |
| Oct 03 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
| Oct 05 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Chairperson of the ... | Option Exercise | A | 23.63 | 25,000 | 590,750 | 25,000 | |
| Oct 02 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 21.61 | 1,000 | 21,610 | 1,000 | |
| Oct 02 2007 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 21.61 | 1,000 | 21,610 | 1,000 | |
| Oct 02 2007 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 21.61 | 1,000 | 21,610 | 1,000 | |
| Oct 02 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 21.61 | 1,000 | 21,610 | 1,000 | |
| Oct 02 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 21.61 | 1,000 | 21,610 | 1,000 | |
| Sep 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 39,384 | |
| Sep 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.75 | 687 | 14,255 | 0 | 687 to 0 (-100.00 %) |
| Sep 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.50 | 500 | 10,250 | 687 | 1.2 K to 687 (-42.12 %) |
| Sep 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.42 | 500 | 10,210 | 1,187 | 1.7 K to 1.2 K (-29.64 %) |
| Sep 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.40 | 500 | 10,200 | 1,687 | 2.2 K to 1.7 K (-22.86 %) |
| Sep 26 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
| Sep 24 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 20.61 | 500 | 10,305 | 2,000 | 1.5 K to 2 K (+33.33 %) |
| Sep 17 2007 | PDLI | PDL BIOPHARMA, INC ... | CROSS HERB | Corp Controller/Pri ... | Grant | A | 0.00 | 3,500 | 0 | 4,122 | 622 to 4.1 K (+562.70 %) |
| Sep 13 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 20.60 | 1,000 | 20,600 | 1,000 | |
| Sep 13 2007 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 20.60 | 1,000 | 20,600 | 1,000 | |
| Sep 13 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 20.60 | 1,000 | 20,600 | 1,000 | |
| Sep 13 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 20.60 | 1,000 | 20,600 | 1,000 | |
| Sep 13 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 20.60 | 1,000 | 20,600 | 1,000 | |
| Sep 13 2007 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 20.60 | 1,000 | 20,600 | 1,000 | |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 41,571 | |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.83 | 437 | 10,414 | 0 | 437 to 0 (-100.00 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.84 | 219 | 5,221 | 437 | 656 to 437 (-33.38 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.80 | 219 | 5,212 | 656 | 875 to 656 (-25.03 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.79 | 219 | 5,210 | 875 | 1.1 K to 875 (-20.02 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.71 | 219 | 5,192 | 1,094 | 1.3 K to 1.1 K (-16.68 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.61 | 219 | 5,171 | 1,313 | 1.5 K to 1.3 K (-14.30 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.58 | 219 | 5,164 | 1,532 | 1.8 K to 1.5 K (-12.51 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.85 | 218 | 5,199 | 1,751 | 2 K to 1.8 K (-11.07 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.65 | 218 | 5,156 | 1,969 | 2.2 K to 2 K (-9.97 %) |
| Aug 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
| Sep 10 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 20.12 | 500 | 10,060 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
| Aug 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 22,615 | |
| Aug 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.50 | 645 | 14,513 | 0 | 645 to 0 (-100.00 %) |
| Aug 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
| Aug 20 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 22.16 | 500 | 11,080 | 1,000 | 500 to 1,000 (+100.00 %) |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financ ... | Option Exercise | A | 22.10 | 30,000 | 663,000 | 30,000 | |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | Shumate Cynthia Lynn | VP Legal Affrs, Sec ... | Option Exercise | A | 22.10 | 10,000 | 221,000 | 10,000 | |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | McCamish Mark Anthony | SVP & CMO | Option Exercise | A | 22.10 | 20,000 | 442,000 | 20,000 | |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | A | 22.10 | 22,500 | 497,250 | 22,500 | |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP, Mktg & Bus. A ... | Option Exercise | A | 22.10 | 30,000 | 663,000 | 30,000 | |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | CROSS HERB | Corp Controller/Pri ... | Option Exercise | A | 22.10 | 7,200 | 159,120 | 7,200 | |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | Savel Robert Michael II | SVP Technical Opera ... | Option Exercise | A | 22.10 | 10,000 | 221,000 | 10,000 | |
| Aug 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | EVP & CSO | Option Exercise | A | 22.10 | 70,000 | 1,547,000 | 70,000 | |
| Aug 06 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Buy | P | 22.47 | 500 | 11,235 | 500 | 0 to 500 |
| Aug 01 2007 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 23.73 | 1,000 | 23,730 | 1,000 | |
| Jul 31 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 23.73 | 25,000 | 593,250 | 25,000 | |
| Jul 31 2007 | PDLI | PDL BIOPHARMA, INC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 23.81 | 15,000 | 357,150 | 15,000 | |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 43,758 | |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.20 | 697 | 17,564 | 0 | 697 to 0 (-100.00 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.14 | 250 | 6,285 | 697 | 947 to 697 (-26.40 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.53 | 210 | 5,361 | 947 | 1.2 K to 947 (-18.15 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.23 | 210 | 5,298 | 1,157 | 1.4 K to 1.2 K (-15.36 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.17 | 210 | 5,286 | 1,367 | 1.6 K to 1.4 K (-13.32 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.15 | 210 | 5,282 | 1,577 | 1.8 K to 1.6 K (-11.75 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.06 | 200 | 5,012 | 1,787 | 2 K to 1.8 K (-10.07 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.02 | 200 | 5,004 | 1,987 | 2.2 K to 2 K (-9.14 %) |
| Jul 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
| Jul 24 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Payment of Exercise | F | 26.22 | 6,862 | 179,922 | 46,275 | 53.1 K to 46.3 K (-12.91 %) |
| Jul 24 2007 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | EVP & CSO | Payment of Exercise | F | 25.93 | 1,519 | 39,388 | 51,606 | 53.1 K to 51.6 K (-2.86 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 23,260 | |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.12 | 65 | 1,698 | 0 | 65 to 0 (-100.00 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 26.04 | 65 | 1,693 | 65 | 130 to 65 (-50.00 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.94 | 64 | 1,660 | 130 | 194 to 130 (-32.99 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.85 | 64 | 1,654 | 194 | 258 to 194 (-24.81 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.78 | 65 | 1,676 | 258 | 323 to 258 (-20.12 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.76 | 64 | 1,649 | 323 | 387 to 323 (-16.54 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.75 | 65 | 1,674 | 387 | 452 to 387 (-14.38 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.72 | 64 | 1,646 | 452 | 516 to 452 (-12.40 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.70 | 64 | 1,645 | 516 | 580 to 516 (-11.03 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 25.65 | 65 | 1,667 | 580 | 645 to 580 (-10.08 %) |
| Jul 23 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
| Jul 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | EVP & CSO | Payment of Exercise | F | 26.22 | 1,447 | 37,940 | 53,125 | 54.6 K to 53.1 K (-2.65 %) |
| Jul 05 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.42 | 62 | 1,452 | 0 | 62 to 0 (-100.00 %) |
| Jul 05 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.35 | 150 | 3,503 | 62 | 212 to 62 (-70.75 %) |
| Jul 05 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.55 | 60 | 1,413 | 212 | 272 to 212 (-22.06 %) |
| Jul 05 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.45 | 26 | 610 | 272 | 298 to 272 (-8.72 %) |
| Jul 05 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.46 | 4 | 94 | 298 | 302 to 298 (-1.32 %) |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 23.89 | 15,000 | 358,350 | 15,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 23.89 | 5,000 | 119,450 | 5,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 23.89 | 500 | 11,945 | 500 | |
| Jun 22 2007 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 23.89 | 5,000 | 119,450 | 5,000 |